CSIMarket
 
Absci Corp  (NASDAQ: ABSI)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Absci Growth Comparisons

Select each growth Category to receive further Information



ABSI Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 128.63 % 0.93 % 7.29 % 3.85 %
Q / Q Revenue Growth (Q3 MRQ) 33.94 % 1.64 % 2.75 % 0.31 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) -39.35 % 38.72 % 5.66 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 29.45 % 1.61 % 1.77 % 1.08 %
Revenue 5 Year Average Growth - 10.51 % 7.98 % 7.78 %


ABSI's Growth Comparisons in III. Quarter 2024




Reporting 128.63% surge year on year in the third quarter 2024 Revenue, Absci led the 0.93% growth in the Medical Laboratories industry, and 7.29% growth in the Healthcare sector. Although the Medical Laboratories industry's Sales gains were softer then 3.85% overall market growth, Absci Corp and the Healthcare sector have delivered above average market Sales growth.

Company's sequential top-line increase was 33.94% from the second quarter. Average annual sales rise for Absci is %, while S & P 500's average yearly sales growth is 7.78% over the five years, including only Businesses with the third quarter 2024 Results.

ABSI Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
Total
128.63 %
33.94 %


Growth Rates of ABSI's Income in the third quarter 2024


ABSI Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - -15.63 % 80.17 % 4.2 %
Seq. Operating Income Change (Q3 MRQ) - -14.96 % 33.25 % -2.5 %
Y / Y Operating Income Growth (Q3 TTM) - 75.7 % -5.97 % 9.01 %
Seq. Operating Income Growth (Q3 TTM) - 1.98 % 20.01 % 1.35 %
Operating Income 5 Year Avg. Change - 3.56 % 6.03 % 9.17 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - -31.69 % 288.36 % -1.77 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - -31.38 % 119.49 % -8.86 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - 111.91 % 24.83 % 8.52 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - 2.31 % 57.04 % -0.09 %
Income from Cont. Ops. 5 Year Avg. Change - 1.37 % -9.86 % 7.33 %

ABSI Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - -36.65 % 7.92 % -6.46 %
Q / Q Net Income Growth (Q3 MRQ) - -34.6 % 133.12 % -6.89 %
Y / Y Net Income Change (Q3 TTM) - 102.96 % -11.98 % 4.97 %
Seq. Net Income Change (Q3 TTM) - 2.17 % 2.61 % -1.42 %
Net Income 5 Year Avg. Growth - 1.35 % -3.49 % 7.48 %

ABSI's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - -32.5 % 288.36 % -1.77 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - -32.91 % 119.49 % -8.86 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth - -8.94 % -9.86 % 7.33 %



ABSI EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - -37.4 % 7.92 % -6.46 %
Q / Q EPS Net Growth (Q3 MRQ) - -36.05 % 133.12 % -6.89 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - - - -6.16 %
EPS Net 5 Year Avg. Change - 1.35 % -3.49 % 7.48 %



Absci reported bottom-line of $ -0.24 in the third quarter, compare to $ -0.24 in the same quarter a year ago. Medical Laboratories industry fell by -37.4%, while Healthcare sector increased by 7.92%, and overall market declined by -6.46%.

The company's sequential bottom-line increase was 33.94% from the second quarter. Average annual income per share rise for Absci is %, while S & P 500's average yearly income per share growth is 7.48% over the five years, including only Businesses with the third quarter 2024 earnings results.

ABSI Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - -33.52 % 37.78 % -42.02 %
Seq. Free Cash Flow Change (Q3 MRQ) - -30.7 % 107.53 % -35.84 %
Y / Y Free Cash Flow Change (Q3 TTM) - 77.54 % 4.58 % 3.33 %
Seq. Free Cash Flow Change (Q3 TTM) - 33.12 % 8.1 % -10.66 %
Free Cash Flow 5 Year Avg. Change - 21.87 % 7.07 % 12.03 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - -79.97 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - 42.2 % - -
Seq. Net Cash Flow Change (Q3 TTM) - 103.1 % - -
Net Cash Flow 5 Year Avg. Change - 17.74 % 10.04 % -33.53 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -84.36 % 0.93 % 1.53 % 2.69 %
Seq. Capital Expenditures Change (Q3 MRQ) -85.59 % -8.48 % 5.37 % 3.24 %
Y / Y Capital Expenditures Change (Q3 TTM) -71.63 % 32.46 % 3.86 % 68.3 %
Seq. Capital Expenditures Change (Q3 TTM) -39.42 % 26.49 % 1.87 % -0.53 %
Capital Expenditures 5 Year Avg. Change - 5.86 % 9.35 % 9.04 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com